๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Proteinuria

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy NCT07541287Phase 220 sites๐Ÿ“ Chula Vista๐Ÿ“ Arvada๐Ÿ“ Denver Jade Biosciences, Inc. ยท Tests: JADE101 Finerenone Therapy for Pediatric HSPN With Mild Proteinuria NCT07315191Phase 41 site๐Ÿ“ Beijing Capital Institute of Pediatrics, China ยท Tests: ACEI / ARB+finerenone, ACEI/ARB Study of BHV-1400 in IgA Nephropathy NCT07054684Phase 115 sites๐Ÿ“ Farmington๐Ÿ“ Miami Lakes๐Ÿ“ Miami Lakes Biohaven Therapeutics Ltd. ยท Tests: BHV-1400 The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study NCT06059664Phase 21 site๐Ÿ“ Chapel Hill University of North Carolina, Chapel Hill ยท Tests: Finerenone Oral Tablet, Placebo The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children NCT06890143Phase 31 site๐Ÿ“ Shanghai Children's Hospital of Fudan University ยท Tests: Dapagliflozin+Standard Treatment for 12 weeks,washout period for 4 weeks๏ผŒthen Standard Treatment alone for12 weeks, Staโ€ฆ Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study) NCT02818192n/a1 site๐Ÿ“ Winnipeg University of Manitoba An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases NCT06664814Phase 21 site๐Ÿ“ Bethesda National Human Genome Research Institute (NHGRI) ยท Tests: ManNAc Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa NCT05881447n/a1 site๐Ÿ“ Bagamoyo Swiss Tropical & Public Health Institute Role of Coenzyme Q10 in Chronic Kidney Disease NCT05942027Phase 41 site๐Ÿ“ Tanta Tanta University ยท Tests: Placebo, Co-Enzyme Q10 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN NCT05755386Phase 3131 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ San Francisco Novartis Pharmaceuticals ยท Tests: Placebo, iptacopan Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin NCT07175051Phase 21 site๐Ÿ“ Chicago University of Illinois at Chicago ยท Tests: Empagliflozin (oral) Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) NCT04752293n/a1 site๐Ÿ“ Winston-Salem Wake Forest University Health Sciences Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease NCT06923709Phase 21 site๐Ÿ“ Odense Odense University Hospital ยท Tests: amiloride, Placebo A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria NCT04456816Phase 21 site๐Ÿ“ Aarhus SynAct Pharma Aps ยท Tests: 100 mg AP1189, Placebo Effect Camostat for Kidney Protection in Chronic Kidney Disease NCT06794593Phase 21 site๐Ÿ“ Odense Odense University Hospital ยท Tests: Camostat Mesylate Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/or Proteinuria Using Ultrasound Localization Microscopy NCT07469059n/a1 site๐Ÿ“ Erlangen University of Erlangen-Nรผrnberg Medical School Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN NCT06994845Phase 320 sites๐Ÿ“ Madera๐Ÿ“ Aurora๐Ÿ“ Gainesville Novartis Pharmaceuticals ยท Tests: iptacopan PEPPI Study: Identification of Women at Risk for Placental Dysfunction NCT06115122n/a1 site๐Ÿ“ Oulu Oulu University Hospital ยท Tests: Pre-eclampsia screening program Proteinuria in Pre and Post Transplant NCT01094327n/a1 site๐Ÿ“ Miami University of Miami A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS) NCT07268638Phase 230 sites๐Ÿ“ Chula Vista๐Ÿ“ Garden Grove๐Ÿ“ Los Angeles Akebia Therapeutics ยท Tests: Praliciguat (Part A), Placebo (Part A), Praliciguat (Part B) Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease NCT07405216Phase 41 site๐Ÿ“ Aguascalientes Centenario Hospital Miguel Hidalgo ยท Tests: Dapagliflozin (10mg Tab), Placebo A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines NCT07561957NA2 sites๐Ÿ“ Dublin๐Ÿ“ Dublin St. James's Hospital, Ireland ยท Tests: Use of an electronic digital Application SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome NCT07214818Phase 2, Phase 31 site๐Ÿ“ Al Mansurah Mansoura University ยท Tests: Dapagliflozin, Empagliflozin, Standard Therapy ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank NCT06162546n/a1 site๐Ÿ“ Vienna Christoph Aufricht ยท Tests: Registry The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease NCT06528405Phase 21 site๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: dapagliflozin, Other anti-diabetic drug or no anti-diabetic drug, empagliflozin, canagliflozin Urinary Vitamin C Loss in Diabetic Subjects NCT00071526n/a1 site๐Ÿ“ Bethesda National Institute of Diabetes and Digestive and Kidney Disโ€ฆ Study of WAL0921 in Patients With Glomerular Kidney Diseases NCT06466135Phase 250 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ Tamarac Walden Biosciences ยท Tests: WAL0921, Placebo Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease NCT07260071n/a1 site๐Ÿ“ London King's College London A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria NCT06819826Phase 31 site๐Ÿ“ Guangzhou Biocity Biopharmaceutics Co., Ltd. ยท Tests: SC0062 strength 10mg, Placebo matched to SC0062 Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes NCT05498116Phase 41 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Montelukast, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy